|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Department of Surgery, Southmead Hospital, North Bristol NHS Hospitals Trust, Westbury on Trym, Bristol, UK
2 Molecular and Cellular Biology, Division of Veterinary Pathology Infection and Immunity, University of Bristol, Langford, UK
Correspondence to:
Correspondence to:
MrA R Weale
Department of Surgery, Southmead Hospital, North Bristol NHS Hospitals Trust, Westbury on Trym, Bristol BS10 5NB, UK; andy{at}weale.org.uk
Patients with short bowel syndrome require long term parenteral nutrition support. However, after massive intestinal resection the intestine undergoes adaptation and nutritional autonomy may be obtained. Given that the complications of parenteral nutrition may be life threatening or result in treatment failure and the need for intestinal transplantation, a more attractive option is to wean patients off nutrition support by optimising the adaptive process. The article examines the evidence that after extensive small bowel resection adaptation occurs in humans and focuses on the factors that influence adaptation and the strategies that have been used to optimise this process. The review is based on an English language Medline search with secondary references obtained from key articles. There is evidence that adaptation occurs in humans. Adaptation is a complex process that results in response to nutrient and non-nutrient stimuli. Successful and reproducible strategies to improve adaptation remain elusive despite an abundance of experimental data. Nevertheless given the low patient survival and quality of life associated with other treatments for irreversible intestinal failure it is imperative that clinical research continues into the optimisation of the adaptation.
Abbreviations: HPN, home parenteral nutrition; SCFA, short chain fatty acid; LCFA, long chain fatty acid; IGF-I, insulin-like growth factor I; IGF-II, insulin-like growth factor II; EGF, epidermal growth factor; TGF
, transforming growth factor
; HBEGF, heparin binding epidermal epidermal-like growth factor; GLP2, glucagon-like peptide 2; HGF, hepatocyte growth factor
Keywords: intestinal failure; intestinal transplantation; parenteral nutrition; adaptation
This article has been cited by other articles:
![]() |
E. Q. Haxhija, H. Yang, A. U. Spencer, H. Koga, X. Sun, and D. H. Teitelbaum Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G88 - G98. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |